Further, a more than two-fold increase in the duration of base rigidity at or above 60% was observed when comparing the response of individual patients to PT-141 versus placebo [15]
The transition from injectable to oral GLP-1 receptor agonists is revolutionizing diabetes treatment, making it far more convenient and accessible for patients
Eli Lilly is conducting a Phase 3 programme for retatrutide
However, neither of the treatment groups was associated with the reduction in MHD, whereas MHD at baseline was (M3: \(\beta\)= 0.29, 95% CI 0.46, 0.11
Sleep patterns can be influenced by numerous factors, including weight loss itself, dietary changes, metabolic shifts, and the adjustment period when starting new medications
10.1002/mrd.22285 23